MedPath

Effect of combined probiotic and selenium supplementation in treatment of patients with Alzheimer's disease

Phase 2
Conditions
Alzheimer's disease.
Alzheimer's disease
Registration Number
IRCT20170612034497N5
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Patients with Alzheimer's disease
Individuals aged 55 to 100 years

Exclusion Criteria

Patients with metabolic syndrome
Patients with diabetes
Patients with cardiovascular disease
Patients with chronic infections
Consuming probiotic and/or synbiotic supplements within 8 weeks prior to the study
Taking other forms of probiotics including probiotic yogurt and other fermented foods
Taking antioxidants supplements

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cognitive function. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Mini Mental State Exam (MMSE).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath